Redwood Wealth Management Group, LLC Syndax Pharmaceuticals Inc Transaction History
Redwood Wealth Management Group, LLC
- $133 Billion
- Q2 2024
A detailed history of Redwood Wealth Management Group, LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Redwood Wealth Management Group, LLC holds 250 shares of SNDX stock, worth $4,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250Holding current value
$4,500% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SNDX
# of Institutions
202Shares Held
87.1MCall Options Held
268KPut Options Held
76.8K-
Black Rock Inc. New York, NY7.91MShares$142 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.34MShares$132 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.72MShares$103 Million9.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$86.3 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.89MShares$70 Million1.09% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $1.02B
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...